Fourth Chinese National Consensus Report on the management ofHelicobacter pyloriinfection-Reference-Cited by-同舟云学术

Fourth Chinese National Consensus Report on the management ofHelicobacter pyloriinfection

Published:2013-04-15 Issue:5 Volume:14 Page:211-221
ISSN:1751-2972
Container-title:Journal of Digestive Diseases
language:en
Short-container-title:Journal of Digestive Diseases

Author:

,Liu Wen Zhong¹,Xie Yong²,Cheng Hong³,Lu Nong Hua²,Hu Fu Lian³,Zhang Wan Dai⁴,Zhou Li Ya⁵,Chen Ye⁴,Zeng Zhi Rong⁶,Wang Chong Wen²,Xiao Shu Dong¹,Pan Guo Zong,Hu Pin Jin⁶

Affiliation:

1. Renji Hospital; Shanghai Jiao Tong University School of Medicine; Shanghai; China

2. First Affiliated Hospital of Nanchang University; Nanchang; Jiangxi Province; China

3. Peking University First Hospital; Beijing; China

4. Nanfang Hospital, Southern Medical University; Guangzhou; Guangdong Province; China

5. Peking University Third Hospital; Beijing; China

6. First Affiliated Hospital; Sun Yat-Sen University; Guangzhou; Guangdong Province; China

Publisher

Wiley

Subject

Gastroenterology

Reference57 articles.

1. Barry Marshall 2005 Nobel laureate in medicine and physiology;Lang;Gastroenterology,2005

2. Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma;Gisbert;Aliment Pharmacol Ther,2011

3. European Helicobacter Study Group. Management of Helicobacter pylori infection - the Maastricht IV/Florence Consensus Report;Malfertheiner;Gut,2012

4. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report;Malfertheiner;Gut,2007

5. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia;Moayyedi;BMJ,2000

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of Weiwei granules in the treatment of chronic active Helicobacter pylori gastritis with atrophy based on the TLR4/NF-κB/COX-2 inflammatory signaling pathway;HISTOL HISTOPATHOL;2024

2. Global research trends and hotspots of Helicobacter pylori eradication based on clinical trial registration platforms: A cross-sectional analysis;Clinics and Research in Hepatology and Gastroenterology;2023-12

3. The Efficacy and Safety of Regimens for Helicobacter pylori Eradication Treatment in China;Journal of Clinical Gastroenterology;2023-11-02

4. Vonoprazan-based triple and dual therapy versus bismuth-based quadruple therapy for Helicobacter pylori infection in China: a three-arm, randomised clinical trial protocol;BMC Gastroenterology;2023-07-07

5. Comparing high-dose dual therapy with bismuth-containing quadruple therapy for the initial eradication of Helicobacter pylori infection on Hainan Island: A randomized, multicenter clinical trial;Clinics and Research in Hepatology and Gastroenterology;2023-05